PH Group N=31

Non-PH Group N=134

P

Age, years
Males
Etiology
Coronary disease
Idiopathic dilated
Other
Urgency
 Urgent
Elective
Unknown

Treatment
Beta blockers
ACEi/ARB II
Spironolactone
Digoxin
Diuretics
Hemodynamic parameters
mPAP
sPAP
dPAP
PWP
RAP
CO
PVR
TPG

51.4 (23-65)
25 (80.7%)

12 (38.7%)
7 (22.6%)
12 (38.7%)

5 (16.1%)
24 (77.4%)
2 (6.5%)

 

13 (42%)
20 (64%)
18 (58.1%)
18 (58.1%)
27 (87.1%)

43.8 ± 8.8
66.4 ± 13.5
29.7 ± 7.7
23 ± 7.7
8.8 ± 5.5
3.7 ± 1.4
6.1 ± 2.6
20.3 ± 4.4

49 (18-68)
118 (88%)

38 (28.4%)
52 (39.8%)
44(32.8%)

28 (20.1%)
93 (69.4%)
13 (9.7%)

 

53 (40%)
79 (59%)
74 (55.2%)
55 (41%)
114 (85%)

28.2 ± 8.9
41 ± 13.2
20 ± 11
20.7 ± 8.6
10.2 ± 7.5
3.5 ± 1.2
2.4 ± 1.5
7.4 ± 4

0.68
0.56
0.19

 

 

0.59


0.81
0.75
0.44
0.20
1.00

0.001
0.001
<0.001
0.27
0.66
0.63
0.001
0.001

“PH” group (pre-transplant disproportionate PH); “non-PH” group (pre-transplant absence of or slight PH); mPAP: mean pulmonary artery pressure mmHg; sPAP: systolic pulmonary artery pressure mmHg; PVR: pulmonary vascular resistances mmHg; TPG: transpulmonary gradient; PWP: pulmonary wedge pressure mmHg; CO: cardiac output l/min; RAP: right atrium pressure mmHg; SaO2; arterial oxygen saturation; SvO2: mixed venous oxygen saturation. Age is expressed in terms of median and interquartile range; sex, etiology and treatment in form of frequency and percentage; hemodynamic parameters in means and standard deviations.
Table 1: Clinical and hemodynamic characteristics of patients in baseline condition.